These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 29992674)

  • 21. Choice of generic versus brand-name antidepressants in a regulated prescription drug market: evidence from Taiwan.
    Liu YM; Ou HT; Yang YK
    J Ment Health Policy Econ; 2014 Dec; 17(4):163-72. PubMed ID: 25599280
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of the Minimum Pricing Policy and introduction of brand (generic) substitution into the Pharmaceutical Benefits Scheme in Australia.
    McManus P; Birkett DJ; Dudley J; Stevens A
    Pharmacoepidemiol Drug Saf; 2001; 10(4):295-300. PubMed ID: 11760489
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Generic drug substitution].
    Tamir O; Halkin H; Shemer J
    Harefuah; 2006 Sep; 145(9):691-5, 701. PubMed ID: 17078434
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Perceptions of pharmacists and physicians on generic substitution in a financial crisis context in Northwestern Spain: A qualitative study.
    Mondelo-García C; Mendoza E; Movilla-Fernández MJ; Coronado C
    Health Policy; 2018 Dec; 122(12):1316-1325. PubMed ID: 30201184
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effect of generic competition on the price of brand-name drugs.
    Lexchin J
    Health Policy; 2004 Apr; 68(1):47-54. PubMed ID: 15033552
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluating community pharmacists' perceptions of future generic substitution policy implementation: a national survey from Malaysia.
    Chong CP; Hassali MA; Bahari MB; Shafie AA
    Health Policy; 2010 Jan; 94(1):68-75. PubMed ID: 19762106
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Factors influencing the use of the "not for generic substitution" mention for prescriptions in primary care: a survey with general practitioners.
    Beauvais V; Marque A; Ferté G; Chrusciel J; Souille J; Nazeyrollas P; Sanchez S
    BMC Health Serv Res; 2018 Nov; 18(1):850. PubMed ID: 30419890
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Employer drug benefit plans and spending on prescription drugs.
    Joyce GF; Escarce JJ; Solomon MD; Goldman DP
    JAMA; 2002 Oct; 288(14):1733-9. PubMed ID: 12365957
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Usefulness of prescription of generic drugs for cost containment in pharmaceutics. Analysis in the Community of Navarra].
    Ansa Erice I; Agudo Pascual C; Artazcoz Sanz M; Carnicero Giménez de Azcárate J
    Aten Primaria; 1996 Apr; 17(6):411-4. PubMed ID: 8672647
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A Systematic Review of Physicians' and Pharmacists' Perspectives on Generic Drug Use: What are the Global Challenges?
    Toverud EL; Hartmann K; Håkonsen H
    Appl Health Econ Health Policy; 2015 Aug; 13 Suppl 1(Suppl 1):S35-45. PubMed ID: 25963230
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Exploring factors underlying the attitude of community pharmacists to generic substitution: a nationwide study from Poland.
    Drozdowska A; Hermanowski T
    Int J Clin Pharm; 2016 Feb; 38(1):162-70. PubMed ID: 26620450
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Generic drugs in morocco: survey of physicians].
    Zaoui S; Hakkou F; Filali H
    Therapie; 2011; 66(6):499-506. PubMed ID: 22186075
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Medicare Spending on Brand-name Combination Medications vs Their Generic Constituents.
    Sacks CA; Lee CC; Kesselheim AS; Avorn J
    JAMA; 2018 Aug; 320(7):650-656. PubMed ID: 30140875
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association of authorized generic marketing with prescription drug spending on antidepressants from 2000 to 2011.
    Cheng N; Banerjee T; Qian J; Hansen RA
    J Am Pharm Assoc (2003); 2017; 57(3):341-348. PubMed ID: 28400255
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effects of differences in state drug product selection laws on pharmacists' substitution behavior.
    Carroll NV; Fincham JE; Cox FM
    Med Care; 1987 Nov; 25(11):1069-77. PubMed ID: 3695637
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [How do pharmacists evaluate the newly introduced system of substituting prescriptions?].
    Rubak SL; Andersen ML; Mainz J; Olesgaard P; Laursen K; Schaumann M; Lauritzen T
    Ugeskr Laeger; 2000 Nov; 162(45):6074-7. PubMed ID: 11107945
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Factors influencing consumer purchasing patterns of generic versus brand name over-the-counter drugs.
    Kohli E; Buller A
    South Med J; 2013 Feb; 106(2):155-60. PubMed ID: 23380752
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Generic drug prescriptions following hospital discharge: a prospective study in France.
    Chu C; Rudant E; Bonvalet M; Agostini H; Cavalié P; Bonhomme-Faivre L; Frenkiel J; Taillandier J; Boissonnas A; Vittecoq D; Wyplosz B
    Eur J Intern Med; 2011 Oct; 22(5):e45-9. PubMed ID: 21925042
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prescription prices under the New York generic substitution law.
    Francetić I; Lasagna L; Weintraub M; Karch FE
    Ann Intern Med; 1980 Mar; 92(3):419-23. PubMed ID: 7356236
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Implementing a statin switching programme in primary care: patients' views and experiences.
    Krska J; Allison K; Delargy M; Murray L; Smith H
    Br J Clin Pharmacol; 2012 Jul; 74(1):147-53. PubMed ID: 22257274
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.